These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24947558)
1. Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles. Lee WL; Guo WM; Ho VH; Saha A; Chong HC; Tan NS; Widjaja E; Tan EY; Loo SC Small; 2014 Oct; 10(19):3986-96. PubMed ID: 24947558 [TBL] [Abstract][Full Text] [Related]
2. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading. Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886 [TBL] [Abstract][Full Text] [Related]
3. Altering the drug release profiles of double-layered ternary-phase microparticles. Lee WL; Loei C; Widjaja E; Loo SC J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877 [TBL] [Abstract][Full Text] [Related]
4. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
6. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related]
7. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Lin R; Shi Ng L; Wang CH Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377 [TBL] [Abstract][Full Text] [Related]
8. Designing multilayered particulate systems for tunable drug release profiles. Lee WL; Yu PO; Hong M; Widjaja E; Loo SC Acta Biomater; 2012 Jul; 8(6):2271-8. PubMed ID: 22342827 [TBL] [Abstract][Full Text] [Related]
10. Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2. Kang Y; Wu J; Yin G; Huang Z; Liao X; Yao Y; Ouyang P; Wang H; Yang Q Langmuir; 2008 Jul; 24(14):7432-41. PubMed ID: 18547089 [TBL] [Abstract][Full Text] [Related]
11. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245 [TBL] [Abstract][Full Text] [Related]
12. Prolonging food shelf-life by dual actives release from multi-layered polymer particles. Biswal AK; Saha S Colloids Surf B Biointerfaces; 2019 Mar; 175():281-290. PubMed ID: 30551015 [TBL] [Abstract][Full Text] [Related]
13. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy. Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620 [TBL] [Abstract][Full Text] [Related]
14. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Lu J; Jackson JK; Gleave ME; Burt HM Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176 [TBL] [Abstract][Full Text] [Related]
15. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability. Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of double-walled microspheres for the sustained release of doxorubicin. Tan EC; Lin R; Wang CH J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579 [TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles. Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637 [TBL] [Abstract][Full Text] [Related]
18. Release of hydrophilic drug from biodegradable polymer blends. Tan LP; Hidayat A; Lao LL; Quah LF J Biomater Sci Polym Ed; 2009; 20(10):1381-92. PubMed ID: 19622278 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of skin permeation retardants and enhancers: a comparative study of levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles. Azarbayjani AF; Khu JV; Chan YW; Chan SY Biopharm Drug Dispos; 2011 Oct; 32(7):380-8. PubMed ID: 21815171 [TBL] [Abstract][Full Text] [Related]
20. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents. Indolfi L; Causa F; Giovino C; Ungaro F; Quaglia F; Netti PA J Biomed Mater Res A; 2011 May; 97(2):201-11. PubMed ID: 21394898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]